
Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
Keywords: از; bioresorbable vascular scaffold; health care economics; DES; drug-eluting stent(s); MI; myocardial infarction; PCI; percutaneous coronary intervention;